Investors Research Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$400K Hold
23,891
0.08% 223
2025
Q1
$367K Hold
23,891
0.08% 225
2024
Q4
$527K Sell
23,891
-300
-1% -$6.61K 0.12% 189
2024
Q3
$436K Hold
24,191
0.1% 218
2024
Q2
$393K Sell
24,191
-375
-2% -$6.09K 0.09% 233
2024
Q1
$347K Sell
24,566
-850
-3% -$12K 0.08% 262
2023
Q4
$265K Hold
25,416
0.06% 286
2023
Q3
$259K Hold
25,416
0.07% 284
2023
Q2
$191K Sell
25,416
-200
-0.8% -$1.51K 0.05% 334
2023
Q1
$227K Sell
25,616
-225
-0.9% -$1.99K 0.06% 309
2022
Q4
$236K Sell
25,841
-225
-0.9% -$2.05K 0.06% 296
2022
Q3
$210K Hold
26,066
0.06% 297
2022
Q2
$196K Sell
26,066
-300
-1% -$2.26K 0.06% 316
2022
Q1
$248K Hold
26,366
0.07% 301
2021
Q4
$211K Sell
26,366
-350
-1% -$2.8K 0.06% 299
2021
Q3
$260K Hold
26,716
0.09% 264
2021
Q2
$264K Hold
26,716
0.09% 257
2021
Q1
$308K Sell
26,716
-75
-0.3% -$865 0.12% 242
2020
Q4
$259K Sell
26,791
-1,250
-4% -$12.1K 0.1% 277
2020
Q3
$253K Sell
28,041
-250
-0.9% -$2.26K 0.12% 245
2020
Q2
$349K Sell
28,291
-775
-3% -$9.56K 0.18% 189
2020
Q1
$261K Sell
29,066
-250
-0.9% -$2.25K 0.16% 214
2019
Q4
$287K Sell
29,316
-250
-0.8% -$2.45K 0.13% 235
2019
Q3
$203K Sell
29,566
-25
-0.1% -$172 0.1% 252
2019
Q2
$273K Sell
29,591
-425
-1% -$3.92K 0.14% 203
2019
Q1
$471K Sell
30,016
-300
-1% -$4.71K 0.25% 136
2018
Q4
$467K Buy
30,316
+250
+0.8% +$3.85K 0.33% 130
2018
Q3
$648K Sell
30,066
-551
-2% -$11.9K 0.37% 104
2018
Q2
$745K Buy
30,617
+475
+2% +$11.6K 0.43% 70
2018
Q1
$515K Sell
30,142
-700
-2% -$12K 0.31% 124
2017
Q4
$584K Buy
+30,842
New +$584K 0.36% 100